首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Kidney360

缩写:KIDNEY360

ISSN:2641-7650

e-ISSN:2641-7650

IF/分区:3.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1879
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Laureline Berthelot,Nicolas Degauque,Laura Cappelier et al. Laureline Berthelot et al.
Background: Tolerant kidney transplant recipients without immunosuppression have a high frequency of circulating granzyme B (GZMB)-expressing regulatory B cells (Breg). Since the precursors of these Bregs remain unknown a...
Jonathan S Chávez-Iñiguez,Miguel Ibarra-Estrada,Edgar Joel Carmona-Morales et al. Jonathan S Chávez-Iñiguez et al.
Background: During AKI, iron deficiency may contribute to worse clinical outcome by interfering cellular repair. Correcting iron deficiency with intravenous (IV) dextran iron may reduce the risk of major adverse kidney ev...
Akiko Mii,Shinya Yamamoto,Masamichi Yamamoto et al. Akiko Mii et al.
Background: Energy metabolism is fundamental to organ development, yet its role in determining nephron formation remains poorly understood. Disturbances in the intrauterine environment are known to affect nephron endowmen...
José D González-Barajas,Manuel L Prieto-Magallanes,Carolina Romo-Alvarez et al. José D González-Barajas et al.
Background: CKD is among the strongest predictors of adverse COVID-19 outcomes, yet how CKD-associated risk evolved across pre-vaccination, roll-out, mass-vaccination, and post-pandemic phases remains incompletely defined...
Cristina Riaza,Marta Álvarez-Nadal,Antonio Casado et al. Cristina Riaza et al.
Background: Bevacizumab, a monoclonal antibody targeting VEGF-A, is a cornerstone in ovarian cancer. Bevacizumab is associated with renal adverse events, including hypertension, proteinuria, and acute kidney injury. The i...
Sunil Bhandari,Samir Mehta,Natalie Ives et al. Sunil Bhandari et al.
Background: In the STOP-ACEi trial, patients with advanced CKD were randomised to continue or stop renin-angiotensin system inhibitors (RASi) and showed no difference in kidney outcomes. This post-hoc analysis investigate...
Ankit Shah,Manish Maski,Debbie Goldschmidt et al. Ankit Shah et al.
Background: Apolipoprotein L1 (APOL1)-mediated kidney disease (AMKD) is an aggressive form of chronic kidney disease (CKD). This study described characteristics of non-diabetic patients with AMKD and compared their diseas...